236 related articles for article (PubMed ID: 6410085)
1. Severely contracted bladder following intravesical mitomycin C therapy.
Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
[TBL] [Abstract][Full Text] [Related]
2. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
Baker WC; Russo MA; deVere White RW
Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
[TBL] [Abstract][Full Text] [Related]
3. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
[TBL] [Abstract][Full Text] [Related]
4. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
Katz G; Hackett RL; Wajsman Z
Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
[TBL] [Abstract][Full Text] [Related]
5. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
Drago PC; Badalament RA; Lucas J; Drago JR
J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
[TBL] [Abstract][Full Text] [Related]
6. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
7. [Blood and tissue levels of mitomycin C after intravesical instillation].
Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
[TBL] [Abstract][Full Text] [Related]
8. Intravesical mitomycin C for superficial transitional cell carcinoma.
Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
[TBL] [Abstract][Full Text] [Related]
9. Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
Racioppi M; Porreca A; Foschi N; Delicato G; Destito A; D'Addessi A
Urol Int; 2005; 75(4):373-5. PubMed ID: 16327311
[TBL] [Abstract][Full Text] [Related]
10. Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors.
Wajsman Z; Dhafir RA; Pfeffer M; MacDonald S; Block A; Dragone N; Pontes JE
J Urol; 1984 Jul; 132(1):30-3. PubMed ID: 6427484
[TBL] [Abstract][Full Text] [Related]
11. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
van der Meijden AP; DeBruyne FM
Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
[TBL] [Abstract][Full Text] [Related]
12. Side effects associated with intravesical mitomycin.
Nissenkorn I; Herrod H; Soloway MS
J Urol; 1981 Nov; 126(5):596-7. PubMed ID: 6457917
[TBL] [Abstract][Full Text] [Related]
13. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
14. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.
Shapiro O; Jones K; Wang C; Landas S; Haas GP
Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y
J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
[TBL] [Abstract][Full Text] [Related]
16. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
17. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
[TBL] [Abstract][Full Text] [Related]
18. Renal failure after intravesical mitomycin C.
Farha AJ; Krauss DJ
Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
[TBL] [Abstract][Full Text] [Related]
19. [Intravesical instillation in the treatment of superficial tumors of the bladder].
Chopin DK
Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]